Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A previous study on the association between KEGG pathways and AD revealed that the pathways most closely related to AD pathology-associated genes or targets of approved AD drugs were not necessarily the most extensively studied, highlighting a disconnect between drug development and mechanism research [3]
The benefits may be greater for certain goals, but so are the considerations
To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
Battaini, G., Monzani, E., Casella, L., Santagostini, L
Together, you're building better hardware and running better software simultaneously
US$ 22.93
US$ 25.22
US$ 21.78
US$ 23.18
